Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anaerobic microbial redox enzymes represent a functional class of proteins, such as pyruvate:ferredoxin oxidoreductase (PFOR) and nitroreductases, that are essential for the energy metabolism of anaerobic bacteria and certain protozoa (StatPearls, 2023). These enzymes facilitate electron transfer reactions in the absence of oxygen, often utilizing low-redox-potential carriers like ferredoxin or flavodoxin to drive metabolic pathways (PubMed, 2019). In a therapeutic context, these enzymes are the primary targets for the activation of 5-nitroimidazole prodrugs, including metronidazole and tinidazole (Nature Reviews Microbiology, 2017). The enzymes reduce the nitro group of these drugs to form highly reactive nitro radical anions that cause extensive DNA damage and inhibit protein synthesis within the pathogen (PubChem). Because human cells primarily utilize aerobic respiration and lack these specific low-potential redox systems, these enzymes allow for highly selective antimicrobial activity (Microbiology and Molecular Biology Reviews, 2018). They play a central role in the treatment of anaerobic infections, including those caused by Bacteroides fragilis, Clostridioides difficile, and various parasitic protozoa (NIH, 2022). Resistance to drugs targeting these enzymes often arises through mutations that decrease enzyme expression or through the acquisition of genes that provide alternative metabolic pathways (Journal of Antimicrobial Chemotherapy, 2020).
These enzymes act as activators for prodrugs; they reduce the nitro group of 5-nitroimidazole compounds into reactive radical intermediates that cause DNA strand breakage and inhibit nucleic acid synthesis in anaerobic organisms (StatPearls, 2023; Nature Reviews Microbiology, 2017).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anaerobic microbial redox enzymes.